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Oliguria is a valuable marker of kidney function and a
criterion for diagnosing and staging acute kidney injury (AKI).
However, the utility of urine output as a specific metric for
renal dysfunction is somewhat controversial. To study this
issue further we tested whether urine output is a sensitive,
specific, and early measure for diagnosing and staging AKI in
317 critically ill patients in a prospective observational study.
Urine output was assessed every hour and serum creatinine
every 12 to 24h. The sensitivity and specificity of different
definitions of oliguria for the diagnosis of AKI were compared
with the Acute Kidney Injury Network serum creatinine
criterion. The incidence of AKI increased from 24%, based
solely on serum creatinine, to 52% by adding the urine
output as a diagnostic criterion. Oliguric patients without a
change in serum creatinine had an intensive care unit
mortality rate (8.8%) significantly higher than patients
without AKI (1.3%), and similar to oliguric patients with an
increase in serum creatinine (10.4%). The diagnosis of AKI
occurred earlier in oliguric than in non-oliguric patients.
Oliguria of more than 12h and oliguria of 3 or more episodes
were associated with an increased mortality rate. Thus, urine
output is a sensitive and early marker for AKI and is
associated with adverse outcomes in intensive care unit
patients.
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Acute kidney injury (AKI) is associated with a 40–80%
mortality rate, increased length of hospital stay, and high
costs in critically ill patients.1–4 Even minor changes in renal
function, such as a serum creatinine (sCr) increase of
0.3 mg/dl, are associated with short-term and long-term
mortality and the development of chronic kidney disease.5 It
is still unclear whether these changes are a marker for AKI
severity or direct mediators of the adverse outcomes.
Regardless, the emerging role of declining renal function as
a risk factor for mortality advocates an urgent need for early
recognition and management of AKI. These data have
catalyzed the search for novel, more sensitive, and specific
biomarkers to detect AKI earlier. Several candidates are
undergoing prospective validation: neutrophil gelatinase-
associated lipocalin, kidney injury molecule-1, liver fatty
acid-binding protein, a- and p-glutathione S-transferase.6–9
Although oliguria is a frequent event in intensive care unit
(ICU) patients and urine flow has been proposed as a
diagnostic and staging criterion for AKI, none of the
biomarker studies have focused on urine output (UO) as a
renal biomarker. Most of the previous studies were derived
from analysis of retrospective data, and the UO criterion, if
not omitted, was modified, confirming that its application is
challenging and that further studies are required to validate
this criterion.
We believe that urine flow rate is a sensitive and specific
biomarker that provides an early warning signal for
impending renal dysfunction. We hypothesized that the UO
criteria would increase the sensitivity and specificity of the
Acute Kidney Injury Network (AKIN) classification system,
as oliguric patients without sCr change would have an
increased mortality, dialysis requirements, and longer lengths
of ICU stay than non-AKI patients. In addition, we
hypothesized that changes in urine volume would be an
earlier marker of AKI in comparison with the sCr criterion.
We assessed different definitions of oliguria to determine
whether the current standard for AKI diagnosis and staging is
optimal in comparison with alternate criteria.
RESULTS
Incidence of oliguria
This study included 317 patients. We assessed the incidence
of oliguria using different definitions as presented in Figure 1.
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One hundred and fifty one patients (47%) had an episode of
oliguria during their ICU stay. More patients were classified as
oliguric using the total urine volume over a 6-h period
(olig6-moving blocks (mblock) and olig6-fixed blocks
(fblock)) compared with the current AKIN UO definition,
which requires 6 consecutive hours with o0.5 ml/kg
(olig6 consecutive (consec)). Patients who met olig6-consec
definition had the highest rate of progression to AKIN stage 2
based on UO criterion, 74/94 (79%). Of these 74, 15 (20%)
progressed to olig24 (UO o7.2 ml/kg in 24 h or anuria for
12 h). Olig6-mblock was the most sensitive definition, but had
the lowest rate of progression: 70/150 (52%) to stage 2 and 15
(19%) to olig24. The rate of progression of patients who had
met olig6-fblock was 64% to olig12 and 19% to olig24.
Table 1 shows the sensitivity, specificity, and positive and
negative predictive values of the different oliguria definitions
based on AKIN sCr criterion as the gold standard for AKI
diagnosis. Olig6-mblock had the highest sensitivity (0.54)
and olig6-consec the highest specificity (0.71). Increasing the
time frame to detect oliguria from 6 to 12 h (olig12) and to
24 h (olig24) increased the specificity, but markedly decreased
the sensitivity compared with the AKIN sCr definition.
Within any 6-h interval, olig6-fblock had the best positive
and negative predictive values. We used olig6-fblock (i.e.,
o3 ml/kg during a 6-h fblock) to further classify the patients
into four groups: non-AKI, non-oliguric AKI, oliguric
with sCr change (Type A), and oliguric without sCr change
(Type B).
Of 150 oliguric patients, 64 (42%) had prolonged oliguria
(12 h), and 15 (10%) had anuria for 12 h or oliguria for 24 h
(AKIN UO Stage 3). We evaluated the distribution of
co-morbidities and potentially modifiable acute risk factors
for AKI in patients with olig6 and in patients with prolonged
oliguria (olig12 and olig24). Patients with prolonged oliguria
had more associated co-morbidities and higher incidence of
acute risk factors (Table 2). Length of ICU and hospital stay
was not different among patients classified by maximum
AKIN stage by UO criterion. Need for dialysis and mortality
rate was significantly higher in patients classified as stage
3 by UO criterion (Figure 2).
AKI staging progression
At AKI diagnosis of the 167 patients, 56 were non-oliguric
(sCr changes alone) and 111 were oliguric (olig6-fblock
definition; Figure 3). One hundred and sixty five patients were
classified as AKIN stage 1 and two patients were classified as
AKIN stage 2 (by the sCr criteria). Fifteen non-oliguric
patients had an episode of oliguria after AKI diagnosis and
were classified as Type A group (sCr and oliguria by olig6-
fblock), based on maximum stage during ICU stay. Of the
oliguric patients, 21 subsequently had sCr changes and were
also classified as Type A (sCr and oliguria by olig6-fblock).
Based on maximum AKIN stage reached, 41 patients were
non-oliguric, 36 had oliguric AKI with sCr elevation (Type A)
and 90 were oliguric without change in sCr (Type B). Fifteen
patients progressed to AKIN stage 2 exclusively by sCr
criterion, 8 by both sCr and oliguria criteria, and 71
exclusively by oliguria criteria. A total of 22 patients reached
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Figure 1 |Patient classification as AKI by AKIN classification
system and the proposed oliguria definitions. Definitions:
Olig6 con (AKIN stage 1 urine output criterion): o0.5 ml/kg/h for
at least 6 consecutive hours. Olig6-mblock (modified criterion):
o3 ml/kg during any 6-h period (e.g., 0600–1200 or 0700–1300
hours). Olig6-fblock (modified criterion): o3 ml/kg during a 6-h
fblock (e.g., 0600–1200 hours). Olig12o6 ml/kg during a 12-h
block. Olig24 o7.2 ml/kg in 24 h or anuria X12 h. AKI, acute
kidney injury; AKIN, Acute Kidney Injury Network; fblock, fixed
block; mblock, moving block; Olig, oliguria; SICU, surgical
intensive care unit. * indicates outliers.
Table 1 | Sensitivity, specificity, positive, and negative predictive values for UO criteria based on serum creatinine as the
standard diagnostic criteriaa
AKIN Stage 1
Stage 2 Stage 3
Olig6-consecb Olig6-mblock Olig6-fblock Olig12 Olig24c
No. of patients 94 150 126 79 15
Sensitivity 0.34 (0.24–0.45) 0.53 (0.41–0.64) 0.47 (0.35–0.58) 0.30 (0.20–0.41) 0.08 (0.03–0.17)
Specificity 0.71 (0.65–0.77) 0.54 (0.48–0.61) 0.62 (0.56–0.68) 0.76 (0.70–0.81) 0.96 (0.92–0.98)
Positive predictive value 0.27 0.27 0.28 0.29 0.37
Negative predictive value 0.77 0.78 0.79 0.77 0.76
Abbreviations: AKIN, Acute Kidney Injury Network; consec, consecutive; fblock, fixed block; mblock, moving block; Olig, oliguria; UO, urine output.
aAKIN stage 1 serum creatinine criterion: absolute 0.3 mg/dl or relative 50% increase from reference serum creatinine within 48 h.
bAKIN stage 1 urine output criterion.
cUrine output o7.2 ml/kg in 24 h or anuria for 12 h.
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Stage 3 criteria; 7 exclusively by sCr, 1 by both criteria, and 14
exclusively by oliguria criteria (Figure 3).
Table 3 compares the demographic and patient character-
istics at ICU admission of non-AKI patients, non-oliguric
patients, and Type A and B oliguric patients. There was no
difference in the number of patients with chronic kidney
disease or the reference sCr level among groups. However,
Type A oliguric patients were older and had more
co-morbidities, with a higher incidence of diabetes mellitus,
hypertension, and obesity. Type A oliguric patients also had
higher incidence of sepsis and hypotension, required
mechanical ventilation and were exposed to nephrotoxic
drugs more often.
Time to reach diagnostic criteria
We calculated the time to reach AKI diagnosis from ICU
admission by oliguria and by sCr criteria. Type B oliguric
patients were diagnosed earlier than non-oliguric AKI (UO
12 h (interquartile ratio (IQR) 6–24) vs. sCr 24 h (IQR
12–37); P¼ 0.008; Figure 4). In patients who met both
criteria (Type A), there was no significant difference in time
to reach UO or sCr diagnosis; UO 12 h (IQR 6–27) vs. sCr
14 h (IQR 7–23); P¼ 0.36.
Outcomes by AKI diagnostic criteria
The frequency to require renal replacement therapy was
different among the groups of AKI diagnosis, but not
significantly different between Type A (2.2%) and Type B
(13.9%; P¼ 0.20) oliguric patients. The lengths of ICU and
hospital stay were shorter in non-AKI than in Type B oliguric
patients. The ICU length of stay was 2 (IQR 2–3) in non-AKI
versus 3 (IQR 2–7) in Type B (Po0.001). Hospital length of
stay was 6 (IQR 3–13) in non-AKI versus 8 (IQR 4–17) in
Type B (P¼ 0.02). The overall mortality rate was 5.6% and
varied in each group (Figure 5). The mortality rate in AKI
patients was 9.5%, compared with 1.3% in non-AKI patients
(P¼ 0.001). Type B oliguric patients had a significantly
higher mortality rate than non-AKI patients (non-AKI 1.3 vs.
8.8% olig6-fblock; P¼ 0.007). Applying the UO criterion
in addition to the sCr criterion, increases the area under
the curve to predict mortality for AKI from 0.60 (95%
confidence interval 0.46–0.75; P¼ 0.12) to 0.69 (95%
confidence interval 0.58–0.79; P¼ 0.006).
Table 2 | Risk factors in patients diagnosed as oliguric AKI
using a moving block method (n=150)
AKIN
Stage 1
AKIN
Stage 2
AKIN
Stage 3
Number of patients olig6-mblock olig12 olig24 P-value
n (% total) 71 (47) 64 (43) 15 (10)
Demographic characteristics
Age years, median (IQR) 52 (35–71) 59 (48–73) 61 (49–70) 0.19
Race—Caucasian 33 (46) 41 (64) 9 (60) 0.27
Gender, male 40 (56) 42 (65) 9 (60) 0.54
BMI (kg/m2), median
(IQR)
27 (23–31) 28 (24–35) 31 (22–38) 0.32
Co-morbidities
Age 470 years 18 (25) 19 (30) 3 (20) 0.70
Diabetes 14 (20) 24 (37) 9 (60) 0.003
Hypertension 21 (30) 26 (40) 5 (33) 0.40
Obesity (BMI430) 21 (30) 24 (37) 8 (53) 0.19
Chronic liver disease 8 (11) 9 (14) 7 (43.8) 0.003
Chronic lung disease 10 (14) 4 (6) 7 (46) o0.001
Congestive heart failure 5 (7) 8 (12) 6 (40) 0.002
Reference sCr (mg/dl),
median (IQR)
0.9 (0.7–1.1) 0.9 (0.8–1.3) 1.0 (0.7–1.4) 0.42
Atherosclerotic disease 8 (11) 11 (17) 7 (46) 0.004
Acute risk factors
Severe infection/sepsis 11 (15) 9 (14) 7 (46) 0.009
Hypotension 23 (32) 18 (28) 12 (80) 0.001
Mechanical ventilation 31 (43) 34 (53) 12 (80) 0.03
pH value p7.30 6 (8) 13 (20) 6 (40) 0.007
Nephrotoxin exposure 10 (14) 11 (17) 6 (40) 0.06
Abbreviations: AKIN, Acute Kidney Injury Network; BMI, body mass index; IQR,
interquartile range; mblock, moving block; olig, oliguria; sCr, serum creatinine.
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Figure 2 |Outcome in oliguric patients. (a) Box plot representing length of ICU and hospital stay and (b) bars showing the need for RRT
and ICU mortality by AKIN staging based on urine output criteria. P-value for difference among the groups: 0.32 for length of ICU stay; 0.98
for length of hospital stay; o0.001 for need for RRT and ICU mortality. P-value for difference between stages 1 and 3: 0.005 for need
for dialysis and o0.001 for mortality. P-value for difference between stages 2 and 3: 0.002 for need for dialysis and o0.001 for mortality.
AKIN, Acute Kidney Injury Network; ICU, intensive care unit; RRT, renal replacement therapy. o and * indicate outliers.
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We evaluated the association of AKI diagnosis and
mortality by adjusting for age, cumulative fluid balance
(from ICU admission to the day of AKI diagnosis by UO or
sCr), sepsis, and need for mechanical ventilation. Table 4
shows that the association of AKI diagnosis with mortality
was maintained in non-oliguric, and Type A and B oliguric
patients after multivariate adjustment.
Hours of oliguria and number of episodes of oliguria in
survivors and non-survivors
The median number of non-consecutive hours with urine
volume o0.5 ml/kg was 10 h (IQR 3–22); 22 h (IQR 12–40)
for patients with at least one episode of oliguria versus 4 h
(IQR 2–7) in patients with no episode of oliguria. Non-
survivors had a statistically significant higher non-consecutive
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Figure 3 |AKIN classification at diagnosis and maximum stage by sCr and urine output criteria. At AKI diagnosis 56 were non-oliguric
(sCr changes alone) and 111 were oliguric (olig6-fblock definition). Fifteen non-oliguric patients had an episode of oliguria after AKI
diagnosis and of the oliguric patients, 21 subsequently had sCr changes and were classified as Type A (sCr and oliguria by olig6-fblock).
On the basis of the maximum AKIN stage reached, 41 patients were non-oliguric, 36 had oliguric AKI with sCr change (Type A),
and 90 were oliguric without change in sCr (Type B). Fifteen patients progressed to AKIN stage 2 exclusively by sCr criterion, 8 by
both sCr and oliguria criteria, and 71 exclusively by oliguria criteria. A total of 22 patients reached Stage 3 criteria; 7 exclusively by sCr,
1 by both criteria, and 14 exclusively by oliguria criteria. AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; fblock, fixed block;
sCr, serum creatinine; SICU, surgical intensive care unit’.
Table 3 | Patient characteristics by AKI diagnostic criteria
Number of patients, n (% total)
Non-AKI
151 (47)
Non-oliguric
AKI 41 (13)
Oliguric with sCr change
(Type A) 36 (12)
Oliguric without sCr
change (Type B) 90 (28) P-value
Demographic characteristics
Age (years), median (IQR) 42 (27–61) 45 (31–58) 54 (43–76) 59 (48–73) o0.0001
Race—Caucasian, n (%) 71 (47.0) 21 (51.2) 18 (50.0) 53 (58.2) 0.262
Gender, male 95 (62.9) 26 (63.4) 24 (66.7) 55 (60.4) 0.568
BMI (kg/m2), median (IQR) 25 (22–29) 24 (22–27) 28 (24–35) 27 (24–34) o0.0001
Reference sCr (mg/dl), median (IQR) 0.8 (0.7–1.0) 1 (0.8–1.2) 1 (0.8–1.3) 0.9 (0.7–1.1) 0.058
Co-morbidities—n (%)
Age 470 years 19 (12.6) 5 (12.2) 10 (27.8) 25 (27.5) 0.009
Diabetes mellitus 19 (12.6) 5 (12.2) 17 (47.2) 29 (31.9) o0.0001
Hypertension 27 (17.9) 9 (22.0) 19 (52.8) 25 (27.5) o0.0001
Morbid obesity 33 (21.9) 4 (9.8) 14 (38.9) 32 (35.2) 0.003
Chronic liver disease 5 (3.3) 7 (17.1) 11 (30.6) 11 (12.1) o0.0001
Congestive heart failure 3 (2.0) 2 (4.9) 11 (30.6) 7 (7.7) o0.0001
Chronic lung disease 7 (4.6) 7 (17.1) 10 (27.8) 9 (9.9) o0.0001
Cerebrovascular accident 28 (18.5) 9 (22.0) 8 (22.2) 22 (24.2) 0.76
Chronic kidney disease 5 (3.3) 2 (4.9) 1 (2.8) 1 (1.1) 0.69
Acute risk factors—n (%)
Severe infection/sepsis 9 (6.0) 6 (14.6) 15 (41.7) 10 (11.0) o0.0001
Hypotension 26 (17.2) 11 (26.8) 17 (47.2) 30 (33.0) 0.001
Mechanical ventilation 57 (37.7) 19 (46.3) 25 (69.4) 43 (47.3) 0.007
pH value p7.30 13 (8.6) 5 (12.2) 12 (33.3) 11 (12.1) 0.001
Nephrotoxin exposure 17 (11.3) 9 (22.0) 11 (30.6) 11 (12.1) 0.014
Abbreviations: AKI, acute kidney injury; BMI, body mass index; IQR, interquartile range; sCr, serum creatinine.
Continuous variables are expressed as median (IQR) and categorical variables as frequency (n) and percentage (%). P-value for the difference among groups.
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number of hours with urine volumeo0.5 ml/kg: 24.5 h (IQR
11.2–37) than survivors: 9 h (IQR 3–21); P¼ 0.002. There was
an increment in mortality rate in patients presenting more
than 12 h of oliguria (Figure 6). Among patients presenting
with oliguria (olig6-fblock), the median number of episodes
was 2 (IQR 1–5). Patients with more than three episodes of
oliguria presented a significant higher mortality rate than
patients with less than three episodes of oliguria (30 vs. 6%;
P¼ 0.01; Figure 6).
DISCUSSION
Oliguria is a frequent event in ICU patients, being the final
pathway for several injuries to renal parenchyma; still oliguria
is also the result of transitory changes in volume status or of
external influences, such as drug administration. Although
the UO is currently included as a criterion to diagnose and
stage AKI, few studies have evaluated if decreased UO
without elevation in sCr is a specific marker of AKI that
correlates with outcomes. A major barrier to the application
of the UO criterion is that accurate hourly UO measurements
have been difficult to obtain. Urine flow measurements are
time-consuming, as urine meters require manipulation,
visual assessment, and manual data recording. In most ICUs,
nurses empty the collection bag every 6 h. These difficulties in
measuring, monitoring, and accurately recording UO have
resulted in a lack of a standardized approach to assessing
changes in UO and identifying of episodes of oliguria.
While oliguria can be considered a marker of renal function
and a criterion that correlates with outcomes, devices providing
a continuous and accurate measurement of urine flow are not
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Figure 5 |Clinical outcomes by AKI diagnosis criteria. (a) Box plot representing length of ICU and hospital stay by AKI diagnostic
criteria. (b) Bars show the need for RRT and ICU mortality. P-value¼ 0.002 among the groups for need for RRT and ICU mortality. Type B
(AKI oliguric without sCr change) versus non-AKI patients: P¼ 0.007 for ICU mortality; P¼ 0.02 for ICU stay (days); and Po0.001 for hospital
stay (days). AKI, acute kidney injury; ICU, intensive care unit; RRT, renal replacement therapy; sCr, serum creatinine. o and * indicate outliers.
Table 4 | Independent predictors for ICU mortality
OR 95% CI P-value
Non-oliguric AKI
Sepsis 9.83 4.17–23.12 0.000
AKI diagnosis 2.96 1.21–7.19 0.017
Type B—oliguric AKI without sCr change (definition olig6-mblock)
AKI diagnosis 5.09 1.69–15.3 0.004
Sepsis 10.91 5.29–22.5 0.000
Type A—oliguric AKI with sCr change
Age 1.01 1.00–1.02 0.041
Sepsis 6.36 2.44–16.5 0.000
AKI diagnosis 5.56 1.22–25.4 0.027
Abbreviations: AKI, acute kidney injury; CI, confidence interval; ICU, intensive care
unit; mblock, moving block; OR, odds ratio; sCr, serum creatinine.
Multivariate analysis adjusting the association of AKI diagnosis (non-oliguric, oliguric
with sCr change, and oliguric without sCr change) and mortality for age, cumulative
fluid balance (from ICU admission to the day of AKI diagnosis by urine output or
sCr), sepsis diagnosis, and need for mechanical ventilation.
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widely available. The hourly information on urine volume,
with more frequent observations of the parameter, could allow
an earlier detection of renal dysfunction. Treating urine flow as
a continuous physiological variable instead of as interval
parameter, would provide more time points for the detection
of AKI. For intervention trials on prevention and treatment of
AKI, accurate hourly monitoring of urine flow would provide
more opportunities for intervention.10 On the other hand, for
retrospective evaluations and prospective epidemiological
studies, the assessment of total urine volume in a longer time
intervals could facilitate the application of the criteria, as most
hospitals do not have digital monitors to record UO hourly.
Balancing the practicality of using longer time intervals against
ascertaining urine flow every hour to diagnose oliguria is
challenging. In our study, we initially compared different
definitions of oliguria to detect changes in UO. As hourly UO
was recorded in the electronic medical record, we developed
the olig6-consec calculation to correspond to the strictest
interpretation of the UO AKIN criterion, requiring the urine
volume to be o0.5 ml/kg every hour during 6 consecutive
hours. The olig6-mblock definition was less strict in accepting a
cumulative decrease in UO to o3 ml/kg over 6 consecutive
hours (Figure 7). However, both these calculations required
computation of urine volume in consecutive 6-h periods,
requiring a moving reference point to define the 6-h period.
This moving reference point adds some complexity to the
calculations, and patients may not be classified as AKI if the
decline in UO varies over a 6-h interval, as shown in Figure 7.
We therefore tested the olig6-fblock and olig12 calculations to
evaluate if applying the criterion in blocks of 6 or 12 h,
matching a nurse’s shift, would facilitate the application
without decreasing the sensitivity and specificity of the
criterion. We demonstrated that assessing the urine volume
in a 6-h interval (olig6-mblock and olig6-fblock) resulted in an
increased sensitivity as compared with olig6-consec. Although
the assessment of the total urine volume over 6 h decreased the
specificity of the criterion, the olig6-fblock definition had the
best positive predictive value for AKI, based on sCr criterion
(Table 1). We also assessed the stage progression based on UO
criterion, and confirmed that patients classified by olig6-
consec, the strictest definition, had a higher rate of stage
progression, and those classified by olig6-mblock and olig6-
fblock had an intermediate rate of progression: 79, 52, and
64%, respectively. As the olig6-fblock definition had the best
overall performance, we used that for the subsequent analysis.
Our study confirmed the finding of previous studies that
applying the UO criterion in addition to the sCr criterion
increases the number of patients diagnosed as AKI. Although
the UO increases the sensitivity of the diagnostic criteria, the
specificity of this criterion has not been defined.11–15 In our
study, the incidence of AKI increased from 24 to 52% (using
sCr criterion only) applying both criteria. Joannidis et al.,11
using SAPS 3 database with more than 16,000 ICU patients,
assessed urine volume in a 24-h interval. In that study, they
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would be classified as AKI by the olig6-mblock definition (urine
volume o3 ml/kg in 6 consecutive hours (light gray rectangle)),
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modified the AKIN UO criterion, classifying patients with
o0.5 ml/kg/h in 24 h as injury by the Risk, Injury, Failure,
Loss, and End-stage Kidney (RIFLE) classification. AKI
patients classified in the first 48 h of ICU by the worst
modified UO criterion had increased mortality in compar-
ison with non-AKI patients. Although oliguric patients had a
higher mortality rate than non-AKI patients, the effect of
adding the UO criterion to sCr to predict mortality has
shown discordant results. Haase et al.12 analyzed patients’
outcome classified by UO independently of sCr criteria.
Applying UO criterion in the first 48 h had a lower predictive
value for in-hospital mortality compared with the sCr
criterion. In a systematic review of studies that used both
creatinine and UO criteria,2 the relative risk for death criteria
was lower than in those using only the creatinine criterion.
However, these studies used modified UO criterion or
applied it in a shorter period of time, first 24 or 48 h. In a
study by Cruz et al.,14 applying the actual RIFLE criteria
during ICU stay, the use of creatinine and UO criteria
together had the strongest predictor of ICU mortality in
multivariable analysis. In our study, patients exclusively
diagnosed by UO criterion had more frequent need for
dialysis, longer length of ICU stay, and higher mortality rate
than patients without AKI. However, we did not record the
reasons for dialysis initiation and cannot attribute the increased
dialysis requirement to a specific factor, e.g., fluid balance.
Additionally, we demonstrated that applying the UO criteria, in
addition to the sCr, increases the ability of the AKIN
classification to predict mortality; the area under the receiver
operating characteristic curve increased from 0.60 when
applying only the sCr criterion to 0.69, including UO and sCr.
An important finding in our study is the significant
relationship of the number of episodes of olig6-fblock, and
duration of oliguria with increased mortality. Although
affected by volume status, use of diuretics and other drugs,
these associations were seen regardless of the utilization of
diuretics and other processes of care elements. These data
suggest that closer monitoring of UO and evaluation of the
duration and frequency of oliguria could serve as risk
markers for adverse events. Defining oliguria on the basis
of the total volume of urine in a 6-h interval facilitates
the application of the criteria for prospective and retro-
spective epidemiological studies of AKI. However, in clinical
practice, the hourly urine flow provides more precision
for risk assessment and establishes early time for interven-
tions. Ideally, it would be preferable to have devices that
record UO in real time that display the information
with warnings when the UO has decreased below a set
threshold.16
A key issue is whether UO would provide an earlier
indication of renal dysfunction than sCr. As measurements of
sCr and UO were not done at the same time intervals, it is
difficult to make an exact comparison. While in oliguric AKI
patients the difference to reach UO or sCr was not significant,
time to reach AKI diagnosis by the UO criterion was shorter
than by sCr criteria (Figure 4). However, in a sub-analysis of
patients (data not shown) with sCr available every 12 h, the
difference in time to reach the criteria was not significant.
This fact emphasizes the importance of timed interval
samples determining the accuracy of a biomarker. In patients
at risk for AKI, more time points for sCr measurements could
potentially increase the accuracy of this biomarker.17 This
would need to be determined in future studies. Additionally,
as AKI patients are not in steady state and usually exhibit
positive fluid balance, the diagnosis of AKI based on sCr may
be delayed by 48–72 h, comparing to more sensitive
biomarkers of kidney injury.6–9 The importance of early
detection of AKI has been emphasized, as earlier diagnosis
would provide a wider window to perform supportive and
therapeutic interventions.18
Our study has several strengths. We collected data in a
prospective manner. The patient population was heteroge-
neous (women, Hispanics, and African Americans), and we
applied UO criteria during the entire ICU stay. However, our
study was limited to a single surgical ICU with relatively
short length of stay. As baseline sCr prior to hospitalization
was not known in all patients, we computed changes using
ICU admission sCr as the reference point. Consequently,
some patients who had elevated sCr values at admission may
have been misclassified as not having AKI based on the sCr
criteria. Data regarding the severity of illness was not
available, and we could not determine the differences in
severity between the three groups of AKI patients (non-
oliguric, oliguric with sCr change, and oliguric without sCr
change). More importantly, we were unable to determine
whether volume status in these patients was optimized first,
prior to applying definitions of oliguria to diagnose AKI.
Nevertheless, the high incidence of oliguria, its association
with adverse outcomes, and the shorter time to AKI diagnosis
based on UO criterion highlights the importance of the
application of this criterion, regardless of the utilization of
diuretics and other processes of care elements.
In conclusion, UO is a sensitive and specific criterion for
AKI. Applying both UO and sCr can identify additional
patients with AKI compared with the application of sCr
criterion alone. Oliguric patients without change in sCr have
an increased mortality, increased dialysis requirements, and
longer lengths of ICU and hospital stay than patients without
AKI. We believe that urine flow rate is a sensitive and specific
biomarker that provides an early warning signal for
impending renal dysfunction. Coupled with other biomar-
kers for AKI, urine flow could be used as an early and
meaningful diagnostic criterion, and should be included in
future studies in AKI.
MATERIALS AND METHODS
The study cohort is derived from patients screened for a multicenter
prospective observational study in critically ill patients at risk for
AKI between July 2006 and December 2008 at three academic
centers (University of California, San Diego, University of Alabama,
and Universite´ de Montre´al). We analyzed data from a cohort of 317
surgical ICU patients screened at the University of California,
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San Diego Medical Center. Patients were screened at ICU admission
for potential study participation. Patients were eligible for enroll-
ment if they were aged 18 years or older and had life expectancies of
at least 48 h. Patients were excluded if they had AKI according to the
AKIN criteria,11 were admitted to the ICU 448 h prior to screening,
transferred from another ICU, had a sCr 4177 mmol/l p3 days
before ICU admission, were prisoners, received dialysis within the 12
months prior to admission, had a functioning kidney transplant,
were on anticoagulants or warfarin within the last 7 days, suffered
from decompensated cirrhosis, had chronic kidney disease stage 5,
were anemic (hemoglobin o90 g/l or hematocrit o27%) or were
already enrolled in another research project. The Institutional
Review Board approved a retrospective analysis of all patients
screened for the study, and a waiver of individual authorization for
use of Protected Health Information was granted as stipulated by the
Health Insurance Portability and Accountability Act rules.
We recorded demographic data, co-morbidities, clinical history,
and lab studies from the day of ICU admission until ICU discharge.
sCr was available at least once per 24 h. We applied the AKIN criteria
to define AKI by sCr (creatinine changeX0.3 mg/dl orX50% from
reference within 48 h). We considered the first sCr measured at ICU
admission as the reference sCr. We computed daily and cumulative
fluid balance for each patient; however, we did not record details of
the type and duration of fluid administration or use of diuretics and
other medications.
We classified patients by three different definitions of oliguria on
a 6-h time interval (Table 1). Each of these oliguria definitions was
compared with AKIN sCr criteria for diagnosing AKI. The oliguria
duration over ICU stay was assessed by the number of olig6-fblock
episodes and by the total number of hours during which the patient
had a urine volume o0.5 ml/kg during the ICU stay. We classified
patients at time of diagnosis as oliguric or non-oliguric. Patients
reaching oliguria diagnosis before elevation of sCr were classified as
being diagnosed by oliguria criterion, and those reaching sCr
criterion first were classified as non-oliguric at diagnosis. We
additionally assessed the maximum stage reached throughout the
course of ICU stay. On the basis of this maximum AKIN stage
(either UO or sCr), we stratified patients on one of three categories:
non-AKI, non-oliguric AKI, oliguric with sCr change (Type A), and
oliguric without sCr change (Type B). Patients with no AKI by either
criterion were compared with non-oliguric AKI and with Type A
(with sCr changes) and B (without sCr changes) oliguric patients.
We compared demographics and risk factors for AKI in these groups
of patients. We assessed the rate of progression to more severe stages
of AKI, need of renal replacement therapy, length of ICU, and ICU
mortality in these patients by AKI diagnosis. We calculated the time
to reach AKI diagnosis from ICU admission by oliguria and by sCr
criteria. In Type A oliguric AKI patients, the time to reach the
criteria was compared.
Statistical analyses
Continuous variables were expressed as mean±s.d. and analyzed by
unpaired Student’s t-test, or Wilcoxon rank-sum test, as appro-
priate. Non-parametric variables were expressed as median and
25–75 percentiles and analyzed by Mann–Whitney’s test. Categorical
variables were analyzed by Pearson’s two-test or Fisher’s exact test,
whenever appropriate. The predictive value of UO on AKI diagnosis
was performed using a receiver operator characteristic curve,
and the area under the curve was computed. All statistical tests
were two-sided, and Po0.05 was considered to be significant.
A multivariate stepwise logistic regression was used to assess the
association of AKI diagnosis and mortality. We evaluate the
association of AKI diagnosis using only sCr criterion and including
UO criterion. We adjusted the association of AKI diagnosis and
mortality for age, cumulative fluid balance (from ICU admission to
the day of AKI diagnosis by UO or sCr), sepsis, and need for
mechanical ventilation. Statistical analyses were conducted using
SPSS 17.0 (Chicago, IL).
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